Emerging data suggest Retatrutide , a dual stimulator targeting both the gut-brain axis and GIP , may provide a promising advancement for weight management . Preliminary patient investigations have shown substantial losses in body tissue, potentially outperforming current body composition medications . Despite this, more study is needed to fully… Read More